Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - TOTAL DEBT REPAID
Total Debt Repaid URGN - UroGen Pharma Ltd.
24.5 M
LAST VALUE
-49.44%
2 YEAR CAGR
0.00%
5 YEAR CAGR
43.82%
10 YEAR CAGR